v3 Template
M

Medincell

Healthcare / Biotechnology ~340 employees
Founded
--
Employees (Est.)
~340
17 leaders known
Total Funding
$6.0M
Funding Rounds
1
Last Funding
2024-04-08

About Medincell

Medincell is committed to creating better medicines for all by impacting global health through purposeful innovation. Their mission involves developing an innovative and diverse portfolio of breakthrough therapies using cutting-edge long-acting injectable technology to enhance treatment efficiency, accessibility, and the quality of life for patients worldwide. They collaborate with leading pharmaceutical entities and foundations to introduce groundbreaking therapeutic solutions.

Products & Services

UZEDY(r):A monthly and every 2 months subcutaneous risperidone treatment for schizophrenia.
mdc-TJK:An investigational once-monthly subcutaneous long-acting injection of olanzapine for schizophrenia, with a favorable safety profile. Currently in Clinical Phase 3, developed in partnership with Teva Pharmaceuticals.
mdc-CWM:A one-time intraarticular celecoxib injection for post-operative pain relief after Total Knee Replacement surgery, potentially active for up to three months. Currently in Clinical Phase 3, developed in collaboration with Arthritis Innovation Corporation (AIC).
BEPO(r) Technology:A proprietary technology platform used to develop long-acting injectable treatments.

Specialties

Long-acting injectable technology Schizophrenia treatment Post-operative pain relief Therapeutic care delivery Collaborative pharmaceutical innovation

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant 		A: 6000000
MR: -
FA: up to US$ 6 million
FAN: 6000000 		D: 2024-04-08
FD: 2024-04-08 		1 investors
Grant Latest
2024-04-08
$6.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Christophe Douat

CEO

LinkedIn (Pro only)
R

Richard Malamut

Chief Medical Officer

LinkedIn (Pro only)
S

Sébastien Enault

Chief Business Officer

LinkedIn (Pro only)
J

Julie Alimi

General Counsel and Chief Corporate Development Officer

P

Philippe Moyen

Chief Operating Officer

G

Grace Kim

Chief Strategy Officer, U.S. Finance

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

Medincell Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare / Biotechnology
Company Size
~340 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro